Year: 2016
Type: dissertation
Abstract: Alzheimer’s disease (AD) is the most common neurodegenerative disorder, which is characterized by two major hallmarks: deposition of Aβ plaques and incorporation of neurofibrillary tangles composed by hyperphosphorylated Tau (NFTs). Recently, progress has been made in the comprehension of AD mechanisms, however neither disease modifying treatments nor biomarkers capable of detecting the disease at early stages have been discovered. Several studies supported the hypothesis that Tau pathology spreads throughout the brain, particularly by a mechanism involving extracellular Tau release and subsequent uptake by synaptically connected neurons. Thus, it is supposed that extracellular Tau species are responsible for Tau seeding and spreading of Tau pathology. Although several studies have investigated extracellular Tau, it not yet clear which Tau species is responsible for transmission of Tau pathology, with some authors considering Tau oligomers, while others consider larger aggregated filamentous Tau as the pathogenic Tau species. Particularly, a study performed in P301S mice using an in vivo microdialysis technique demonstrated Tau protein in interstitial fluid. However, little is known about the biochemical properties of the extracellular Tau found. Thus, in this project, the objective was to characterize ISF Tau perfused from P301S mice by a 1 MDa microdialysis probe, using different biochemical assays. Furthermore, the focus was to uncover which Tau species are present in the extracellular space at very early stages of Tau pathology. Our results suggest that the vast majority of Tau present in ISF of 3-month old P301S mice is fragmented, particularly in two abundant fragments, one from N-terminal to PRD and other in MTBD/C-terminal region. To a minor extent, also full-length and most C-terminal Tau was detected. Importantly, mouse endogenous Tau was found in ISF samples from WT mice, however at much lower concentration. Although these two cleavage processes seem evident, it is hypothesized that multiple Tau fragments are present in ISF, but may only be detected depending on the specificity for a particular region of the antibody combination used. Furthermore, the in vivo microdialysis technique was confirmed as a manner to investigate ISF Tau levels, which may also be used to monitor Tau or antibody levels during a passive immunization treatment.In conclusion, this project provided insight about the nature of extracellular Tau, emphasizing the relevance of the study of these fragments in the discovery of a new Tau pathology biomarker, as well as, for the understanding of Tau pathology mechanisms.
Institution: University of Coimbra
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2606671873
